Concepedia
Statistics
Publications
15
Citations
725
H-Index
13
Active since
2002
Affiliations
AstraZeneca (United States)(Current)
Massachusetts General Hospital
Harvard University
Bournemouth University
Kelly Goodwin is an author at AstraZeneca (United States) specializing in oncology, medicine, and pharmacology.
Publications per year
2002–2021
Cyclic tensile strain and cyclic hydrostatic pressure differentially regulate expression of hypertrophic markers in primary chondrocytes
Marcy Zenobi‐Wong, Mark Siegrist, Kelly Goodwin · Bone · 2003 · 240 citations
Natural Sciences, Cell Biology, Physiology +17
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders, Pei Zhang, Kelly Goodwin et al. · Clinical Cancer Research · 2020 · 101 citations
Medicine, Molecular Biology, Oncology +17
Impact of Age on Outcomes with Immunotherapy in Patients with Non–Small Cell Lung Cancer
Morgan RL Lichtenstein, Ryan David Nipp, Alona Muzikansky et al. · Journal of Thoracic Oncology · 2018 · 89 citations
Medicine, Immunology, Oncology +10
A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor
Ibiayi Dagogo‐Jack, Philicia Moonsamy, Justin F. Gainor et al. · Journal of Thoracic Oncology · 2021 · 63 citations · Full text
Medicine, Oncology, Pharmacology +9
Material properties of interstitial lamellae reflect local strain environments
Kelly Goodwin, Neil A. Sharkey · Journal of Orthopaedic Research® · 2002 · 39 citations
Natural Sciences, Materials Science, Orthopaedic Surgery +17
1–5 of 15